Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion type Assertion NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_head.
- NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion description "[Inhibition of the endocannabinoid receptor CB1 improves insulin sensitivity, lowers glycemia, and slows atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_provenance.
- NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion evidence source_evidence_literature NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_provenance.
- NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion SIO_000772 21633404 NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_provenance.
- NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion wasDerivedFrom befree-20140225 NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_provenance.
- NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_assertion wasGeneratedBy ECO_0000203 NP872387.RA28w7bnFr1kRgH5g4IueiV7pU_ouB98-Lc08GAjLprG0130_provenance.